TITLE

β-blockers as Cardiopulmonary Agents: The Benefits May Not Be Limited to CVD

AUTHOR(S)
Gupta, Rahul
PUB. DATE
August 2010
SOURCE
Internal Medicine Alert;8/29/2010, Vol. 32 Issue 16, p123
SOURCE TYPE
Periodical
DOC. TYPE
Opinion
ABSTRACT
The article presents the author's comments on an observational study by F.H. Rutten and colleagues analyzing the benefits of treating chronic obstructive pulmonary disease (COPD) patients with β-blockers.
ACCESSION #
53774512

 

Related Articles

  • Prevalence of Balance Deficits in Chronic Obstructive Pulmonary Disease. Pallavi, Singh; Shambhovi, Mitra; Lokender, Kumar; Divya, Sharma M. // Physiotherapy & Occupational Therapy Journal;Apr-Jun2014, Vol. 7 Issue 2, p61 

    Background: Although primary path physiology of COPD is pulmonary but extra pulmonary manifestation like skeletal muscles dysfunction, physical capacity etc. are studied. Preliminary Evidence shows deficit in postural control in COPD. We aimed at finding out prevalence of balance deficits in...

  • Observational study on the impact of initiating tiotropium alone versus tiotropium with fluticasone propionate/salmeterol combination therapy on outcomes and costs in chronic obstructive pulmonary disease. Chatterjee, Arjun; Shah, Manan; D'Souza, Anna O.; Bechtel, Benno; Crater, Glenn; Dalal, Anand A. // Respiratory Research;Feb2012, Vol. 13 Issue 2, p1 

    Background: This retrospective cohort study compared the risks of exacerbations and COPD-related healthcare costs between patients with chronic obstructive pulmonary disease (COPD) initiating tiotropium (TIO) alone and patients initiating triple therapy with fluticasone-salmeterol combination...

  • Two-year mortality of patients with COPD in primary health care: an observational study. Minas, Markos; Verrou-Katsarou, Ioanna; Mystridou, Parthena; Apostolidou, Eleni; Hatzoglou, Chrisi; Gourgoulianis, Konstantinos I. // International Journal of General Medicine;2012 Part 2, Vol. 5, p815 

    Background: Chronic obstructive pulmonary disease (COPD) remains a significant cause of morbidity and mortality, with high rates of underdiagnosis. There are no studies about following up COPD patients in primary health care. The aim of the current study was to estimate two-year mortality for...

  • Overtreatment of COPD with Inhaled Corticosteroids - Implications for Safety and Costs: Cross-Sectional Observational Study. White, Patrick; Thornton, Hannah; Pinnock, Hilary; Georgopoulou, Sofia; Booth, Helen P. // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Introduction:Combined inhaled long-acting beta-agonists and corticosteroids (LABA+ICS) are costly. They are recommended in severe or very severe chronic obstructive pulmonary disease (COPD). They should not be prescribed in mild or moderate disease. In COPD ICS are associated with side-effects...

  • Implementing a Palliative Care Trial in Advanced COPD: A Feasibility Assessment (The COPD IMPACT Study). Horton, Robert; Rocker, Graeme; Dale, Andrea; Young, Joanne; Hernandez, Paul; Sinuff, Tasnim // Journal of Palliative Medicine;Jan2013, Vol. 16 Issue 1, p67 

    Background: Patients and caregivers living with advanced chronic obstructive pulmonary disease (COPD) have complex care needs and may benefit from palliative care intervention. Little is known about how best to implement and evaluate such initiatives. Objectives: To determine the feasibility of:...

  • New metered-dose inhaler for bronchospasm associated with COPD.  // Modern Medicine;Jan97, Vol. 65 Issue 1, p48 

    Reports on the US Food and Drug Administration's (FDA) approval of a combination of the anticholinergic bronchodilator ipratropium bromide and the beta2-adrenergic bronchodilator albuterol sulfate for patients with chronic obstructive pulmonary disease.

  • Respiratory remedy. R.M.D. // Cortlandt Forum;11/25/96, Vol. 9 Issue 11, p66 

    Features the use of various bronchodilators for the treatment of obstructive pulmonary diseases. Ratio of drugs to be used; Concern on the effects of atropine on the lungs.

  • Non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. Baldwin, David R.; Allen, Martin B. // BMJ: British Medical Journal (International Edition);1/18/97, Vol. 314 Issue 7075, p163 

    Editorial. Describes a treatment process for acute exacerbation of chronic obstructive pulmonary disease. Use of non-invasive positive pressure ventilation; Summary of the result of the study to determine the efficacy of the treatment procedure; Predictors of success of the treatment.

  • Pulmonary medicine. Pingleton, Susan K. // JAMA: Journal of the American Medical Association;6/19/96, Vol. 275 Issue 23, p1849 

    Discusses some of the advances in therapy for chronic obstructive pulmonary disease (COPD) that have occurred in 1995. The expansion of the evaluation of medical therapy for airflow obstruction; Improvement of ventilation therapy; The evaluation of new surgical approaches for treatment of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics